We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
66 hedge funds and large institutions have $146M invested in Novelion Therapeutics Inc. Common Shares in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more capital invested
Capital invested by funds: $110M → $146M (+$36M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
17% more call options, than puts
Call options by funds: $252K | Put options by funds: $215K
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
0% more funds holding
Funds holding: 66 → 66 (0)
11% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 19
Holders
66
Holders Change
–
Holders Change %
0%
% of All Funds
1.64%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
11
Increased
17
Reduced
19
Closed
10
Calls
$252K
Puts
$215K
Net Calls
+$37K
Net Calls Change
-$2.21M
Top Buyers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$7.46M |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$6.39M |
| 3 |
AC
Armistice Capital
New York
|
+$4.41M |
| 4 |
Millennium Management
New York
|
+$3.35M |
| 5 |
TLCM
Tiger Legatus Capital Management
New York
|
+$1.31M |
